Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2025-12-25 @ 6:32 PM
Study NCT ID:
NCT01096992
Status:
COMPLETED
Last Update Posted:
2019-09-25
First Post:
2010-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-30
First Submit QC Date:
None
Study First Post Date:
2010-03-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-24
Results First Submit QC Date:
None
Results First Post Date:
2019-09-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-24
Last Update Post Date:
2019-09-25
Last Update Post Date Type:
ACTUAL